Physician profile
Daniel L Cortez
NPI 1336414309
$63,364.98
in general payments reported to CMS, 2019-2025
8 companies · $25K in 2025
The $25K reported for 2025 was more than what 98% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,860 · 2020: $3,106 · 2021: $125 · 2022: $452 · 2023: $16K · 2024: $16K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Travel and Lodging: $22K · Food and Beverage: $3,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,287.50 |
| Travel and Lodging | $22,100.26 |
| Food and Beverage | $3,434.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $61,670.62 | 2019-2025 | Aveir, Ensite, Viewmate |
| Medtronic Vascular, INC. | $1,252.48 | 2019 | |
| Biosense Webster, INC. | $191.44 | 2021-2025 | Carto 3 |
| Medtronic, INC. | $86.20 | 2022 | |
| Biotronik INC. | $55.45 | 2019 | |
| Irhythm Technologies, INC. | $47.60 | 2024 | Zio Monitor, Zio Xt Patch |
| Cardiva Medical, INC. | $46.97 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cortez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.